
Sign up to save your podcasts
Or


Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Slate Podcasts4.3
23402,340 ratings
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices

25,876 Listeners

8,493 Listeners

1,377 Listeners

3,554 Listeners

2,843 Listeners

1,000 Listeners

1,029 Listeners

5,625 Listeners

1,872 Listeners

87,438 Listeners

112,759 Listeners

56,879 Listeners

53 Listeners

2,340 Listeners

2,068 Listeners

238 Listeners

23,888 Listeners

10,243 Listeners

1,283 Listeners

5,468 Listeners

16,358 Listeners

1,194 Listeners

447 Listeners

12,351 Listeners

6,431 Listeners

16,145 Listeners

421 Listeners

60 Listeners

416 Listeners

48 Listeners

98 Listeners

7 Listeners

131 Listeners

0 Listeners

47 Listeners